asic1c Antibody

Shipped with Ice Packs
In Stock

Description

ASIC Isoform Context

The acid-sensing ion channel 1 (ASIC1) exists as two primary splice variants in mammals:

  • ASIC1a: Ubiquitously expressed in CNS neurons, mediates proton-gated cation currents, and contributes to acidosis-related pathologies

  • ASIC1b: Predominantly found in sensory neurons, with distinct pH sensitivity compared to ASIC1a

No peer-reviewed studies or commercial antibody products currently reference an "ASIC1c" isoform in humans or model organisms. This suggests either a nomenclature error (e.g., confusion with ASIC3/ACCN3) or reference to a hypothetical/obsolete classification.

Key Research Antibodies Targeting ASIC1

The following table summarizes validated ASIC1-targeting antibodies with cross-reactivity data:

Antibody NameHost SpeciesReactivityApplicationsKey Findings from Studies
ASC06-IgG1 Humanized IgGHuman ASIC1aFunctional blocking, in vitro assaysInhibits ASIC1a-mediated Ca²⁺ influx (IC₅₀ = 3.2 nM), reduces acidosis-induced cell death by 45% at 1 μM
Anti-ASIC1 (#ASC-014) RabbitRat, Human, MouseWB, IHC, IP, ICCDetects ASIC1 in ventrolateral medulla; blocks ASIC1 membrane translocation under acidosis
27235-1-AP RabbitHuman, Mouse, RatWB, IHC, IP, ELISAIdentifies 60-90 kDa bands in lysates; used in studies linking ASIC1 to ischemic stroke recovery

Mechanistic Insights

  • pH-Dependent Stability: ASC06-IgG1 retains structural integrity across pH 5.0–7.4, enabling therapeutic use in acidic microenvironments

  • Calcium Signaling Modulation: ASIC1 blockade reduces intracellular Ca²⁺ by 78% in 6H7 cells (p < 0.001 vs. controls)

  • Membrane Trafficking Inhibition: Anti-ASIC1 antibodies prevent acidosis-induced translocation from nucleus to membrane (82% reduction at 10 μg/mL)

Therapeutic Applications

  • Neuroprotection: 1 μM ASC06-IgG1 increases neuronal survival from 5% to 45% under pH 5.5 conditions

  • Atherosclerosis: ASIC1 inhibition restores ABCA1-mediated cholesterol efflux by 63% in acidotic macrophages (p < 0.01)

  • Cancer Biology: ASIC1 antibody pretreatment reduces acidosis-driven tumor invasiveness by 41% in triple-negative breast cancer models

Critical Research Gaps

  1. No antibodies demonstrate exclusive specificity for purported "ASIC1c" isoforms

  2. Commercial antibodies show variable performance:

    • 27235-1-AP detects higher molecular weight bands (~80-90 kDa) suggestive of glycosylation variants

    • ASC-014 requires antigen retrieval for optimal IHC performance

  3. No studies validate ASIC1 antibody efficacy in non-mammalian systems

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
asic1c antibody; accn2c antibody; Acid-sensing ion channel 1C antibody; ASIC1-C antibody; Acid-sensing ion channel 1.3-C antibody; Amiloride-sensitive cation channel 2-C antibody; neuronal-C antibody; ZASIC1.3 antibody
Target Names
asic1c
Uniprot No.

Target Background

Function
The ASIC1c antibody targets the proton-gated sodium channel, which is activated by a decrease in extracellular pH. This activation leads to rapid desensitization and the generation of a biphasic current with a fast inactivating and a slow sustained phase. The channel exhibits high selectivity for sodium ions and can efficiently transport lithium ions. It also transports potassium ions, albeit with lower efficiency. The channel is nearly impermeable to larger ions such as rubidium and cesium.
Database Links

KEGG: dre:407670

UniGene: Dr.120630

Protein Families
Amiloride-sensitive sodium channel (TC 1.A.6) family, ASIC1 subfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed in central nervous system.

Q&A

What is ASIC1c and how does it differ from other ASIC1 isoforms?

ASIC1c (acid-sensing ion channel 1C) is primarily recognized as a zebrafish-specific ASIC isoform (zASIC1.3), encoded by the accn2c gene. Unlike the well-characterized mammalian isoforms ASIC1a and ASIC1b, ASIC1c has been primarily documented in Danio rerio. The zebrafish ASIC1 family includes three distinct isoforms:

  • ASIC1a (zASIC1.2): Encoded by accn2b

  • ASIC1b (zASIC1.1): Encoded by accn2a

  • ASIC1c (zASIC1.3): Encoded by accn2c

It's important to note that while mammalian species primarily express ASIC1a and ASIC1b variants, no peer-reviewed studies currently reference an "ASIC1c" isoform in humans or other mammalian model organisms .

How do ASIC1c antibodies compare with antibodies targeting other ASIC family members?

Commercial ASIC1c antibodies are primarily species-specific reagents targeting zebrafish proteins. In contrast, mammalian ASIC1 antibodies generally target ASIC1a or pan-ASIC1 epitopes and have been more extensively validated.

Key differences include:

  • Target specificity: ASIC1c antibodies target unique C-terminal epitopes specific to the zebrafish isoform

  • Cross-reactivity: Unlike many mammalian ASIC1 antibodies which often show cross-reactivity across species (human/mouse/rat), ASIC1c antibodies are typically zebrafish-specific

  • Applications: ASIC1c antibodies are primarily validated for ELISA and Western blot applications, while mammalian ASIC1 antibodies have broader application validation including IHC, ICC, IP, and functional studies

What criteria should guide antibody selection for ASIC1c detection in zebrafish studies?

When selecting an ASIC1c antibody for zebrafish research, consider:

  • Epitope specificity: Verify the antibody targets unique regions of ASIC1c not shared with ASIC1a or ASIC1b

  • Validation data: Review Western blot data showing specific detection at the expected molecular weight (~60 kDa)

  • Production method: Antibodies raised against recombinant fragments generally show better specificity than those raised against synthetic peptides

  • Purification method: Antigen-affinity purified antibodies (as indicated for CSB-PA754595XA01DIL) provide superior specificity

  • Application compatibility: Ensure validation for your intended application (typically Western blot and ELISA for most commercial options)

  • Host species: Consider secondary antibody compatibility with your experimental design

Most commercial ASIC1c antibodies are rabbit polyclonal IgGs suitable for Western blot and ELISA applications .

Are there issues with cross-reactivity between ASIC1 antibodies and other zebrafish ASIC isoforms?

Cross-reactivity is a significant concern when working with closely related ion channel family members. For zebrafish ASIC1c antibodies:

  • Sequence homology assessment: The three zebrafish ASIC1 isoforms (a, b, c) share significant homology, particularly in conserved domains

  • Validation requirements: Always validate antibody specificity using:

    • Knockdown/knockout controls

    • Overexpression systems

    • Competing peptide controls

  • Recommended controls: Include lysates from tissues known to preferentially express ASIC1c but not ASIC1a/b

To minimize cross-reactivity issues, some researchers employ epitope tagging strategies (HA, FLAG, etc.) rather than relying on isoform-specific antibodies, particularly for overexpression studies .

What are the optimal conditions for using ASIC1c antibodies in Western blotting applications?

Based on available data for ASIC1c and related ASIC1 antibodies:

Sample preparation:

  • Use phosphate-buffered solution with protease inhibitors

  • For membrane proteins like ASIC1c, include mild detergents (0.05% DDM) in extraction buffers

  • Avoid freeze-thaw cycles of antibody solutions

Western blot protocol:

  • Primary antibody dilution: Typically 1:500-1:1000 for ASIC1 antibodies

  • Incubation: Overnight at 4°C provides optimal signal-to-noise ratio

  • Expected molecular weight: 60-70 kDa (unglycosylated), 80-90 kDa (glycosylated)

  • Recommended positive control: Zebrafish brain tissue lysate

  • Secondary antibody: Anti-rabbit IgG at 1:10,000-16,000 dilution

Optimization notes:

  • Blocking buffer: 5% non-fat milk in TBST typically provides lower background than BSA for ASIC antibodies

  • Signal detection: Infrared imaging systems offer superior quantification compared to chemiluminescence

How can researchers troubleshoot non-specific binding when using ASIC1c antibodies?

Common issues with ASIC1c antibody specificity and their solutions:

  • Multiple bands on Western blot:

    • Verify sample preparation (membrane fraction extraction)

    • Increase antibody dilution (1:1000-1:2000)

    • Pre-adsorb antibody with non-specific peptide

    • Use gradient gels to better resolve ASIC1 isoforms

  • High background in immunostaining:

    • Implement additional blocking steps (normal serum from secondary antibody host species)

    • Include 0.1-0.3% Triton X-100 in antibody diluent

    • Consider antigen retrieval optimization for fixed tissues

    • Use purified IgG fraction rather than whole serum

  • Cross-reactivity with other ASIC isoforms:

    • Validate with recombinant protein standards

    • Pre-adsorb with related peptides

    • Consider knockout/knockdown controls

    • Implement peptide competition assays

How can ASIC1c antibodies be used to investigate subcellular localization and trafficking?

For subcellular localization studies of ASIC1c:

  • Immunofluorescence optimization:

    • Fixation: 4% paraformaldehyde for 15-20 minutes provides optimal epitope preservation

    • Permeabilization: 0.1% Triton X-100 for membrane proteins

    • Antibody dilution: Start with 1:100-1:200 for primary detection

    • Co-localization markers: Include membrane markers (Na⁺/K⁺-ATPase) and organelle markers

  • Trafficking studies approach:

    • Surface biotinylation assays to quantify membrane expression

    • Pulse-chase experiments to track protein movement

    • pH-dependent translocation studies, as ASIC1 membrane trafficking is affected by acidosis

  • Advanced imaging techniques:

    • Super-resolution microscopy for nano-scale localization

    • FRET-based approaches to study protein-protein interactions

    • Live-cell imaging with pH-sensitive probes to correlate localization with function

Based on studies of mammalian ASIC1a, pH changes can trigger significant translocation between subcellular compartments, with anti-ASIC1 antibodies showing the ability to prevent acidosis-induced translocation from nucleus to membrane (82% reduction at 10 μg/mL).

What approaches can be used to study ASIC1c function in zebrafish neurons using antibody-based methods?

To investigate ASIC1c function in zebrafish neurons:

  • Functional blocking experiments:

    • Apply learnings from mammalian ASIC1a blocking antibodies (e.g., ASC06-IgG1)

    • Develop function-blocking ASIC1c antibodies targeting extracellular domains

    • Validate blocking capacity using electrophysiological recording methods

  • Calcium signaling analysis:

    • Combine ASIC1c antibody applications with calcium imaging

    • Quantify changes in pH-dependent calcium influx

    • Compare responses to known ASIC channel blockers (amiloride, PcTx1)

  • Developmental neurobiology applications:

    • Use antibodies to track ASIC1c expression during zebrafish neural development

    • Correlate expression patterns with functional circuit formation

    • Implement morpholino knockdown paired with antibody detection

For experimental design, consider the approach used with mammalian ASIC1a where antibodies like ASC06-IgG1 demonstrated sustained (30 min) and dose-dependent inhibition of up to 80% of acid-induced currents with an IC₅₀ value of 85 ± 6 nM .

How can researchers address pH stability concerns when using ASIC1c antibodies in acidosis studies?

Given that ASIC channels are activated by acidic pH, experiments often require antibody stability under acidic conditions:

  • Antibody stability assessment:

    • Test antibody performance across pH range 5.0-7.4

    • For mammalian ASIC1a antibodies like ASC06-IgG1, no significant degradation or aggregation was observed across this pH range after 6 hours at 37°C

    • Consider formulating antibodies in pH-stabilized buffers for acidosis experiments

  • Technical approach for acidosis studies:

    • Pre-test antibody binding under neutral conditions

    • Apply pH challenge separately from antibody incubation steps when possible

    • Include pH-stable controls in all experiments

    • Consider using F(ab) fragments for improved stability in some applications

  • Alternative strategies:

    • Use epitope-tagged constructs for overexpression studies

    • Consider nanobody-based approaches which may offer superior pH stability

    • Implement proximity labeling methods before pH challenge

What are promising research directions for ASIC1c antibodies in understanding zebrafish neurophysiology?

Future research applications for ASIC1c antibodies include:

  • Comparative neurobiology:

    • Investigate evolutionary divergence between zebrafish ASIC1c and mammalian ASIC1 isoforms

    • Study functional conservation/divergence across vertebrate lineages

    • Map expression patterns in specialized neural circuits unique to zebrafish

  • Therapeutic development platforms:

    • Generate function-modulating antibodies similar to mammalian ASIC1a approaches

    • Screen for isoform-specific modulators using antibody competition assays

    • Develop zebrafish disease models for testing therapeutic antibodies

  • Advanced methodological approaches:

    • Single-molecule imaging combined with electrophysiology

    • In vivo imaging in transparent zebrafish larvae

    • Optogenetic approaches combined with antibody-based detection

  • Disease modeling applications:

    • Study ASIC1c in zebrafish models of stroke and acidosis

    • Investigate potential neuroprotective strategies based on ASIC1c modulation

    • Compare with mammalian systems where ASIC1a blocking antibodies like ASC06-IgG1 demonstrated significant protection against acidosis-induced neuronal death

Comparison of Key ASIC1 Antibodies and Their Applications

AntibodyTarget IsoformHostReactivityApplicationsKey FeaturesReference
CSB-PA754595XA01DILASIC1cRabbitZebrafishWB, ELISAAntigen-affinity purified, targets zebrafish-specific epitope
ASC06-IgG1ASIC1aHuman IgGHumanFunctional blocking, in vitro/in vivo assaysBlocks ASIC1a-mediated Ca²⁺ influx (IC₅₀ = 3.2 nM), Reduces acidosis-induced cell death
Anti-ASIC1 (#ASC-014)ASIC1aRabbitRat, Human, MouseWB, IHC, IP, ICCTargets C-terminus (aa 469-488), Blocks membrane translocation
27235-1-APASIC1RabbitHuman, Mouse, RatWB, IHC, IP, ELISADetects 60-90 kDa bands, Used in stroke recovery studies
N271/44ASIC1MouseHuman, Mouse, RatWBMonoclonal IgG1, Detects ~60kDa

Protocols for ASIC1c Antibody Validation in Different Applications

ApplicationRecommended ProtocolValidation ControlsExpected ResultsOptimization Variables
Western Blot1:500-1:1000 dilution, overnight 4°CZebrafish brain lysate, Peptide competition60-70 kDa band (unglycosylated), 80-90 kDa (glycosylated)Blocking buffer, Membrane isolation method
ELISA1:1000-1:5000 dilutionRecombinant protein standard curveLinear detection range 0.1-10 ng/mLCoating buffer pH, Blocking reagent
ICC/IF1:100-1:500 dilutionExpression system with/without targetMembrane localizationFixation method, Permeabilization
Functional Studies0.1-1.0 μM IgGPatch-clamp electrophysiologyDose-dependent inhibition of acid-induced currentsAntibody format (IgG vs Fab)

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.